“ Therapeutic monoclonal antibodies: scFv patents as a marker of a new class of potential biopharmaceuticals ” (2011) Brazilian Journal of Pharmaceutical Sciences, 47(1), pp. 31–38. doi:10.1590/S1984-82502011000100005.